Safety, Pharmacokinetics and Pharmacodynamics of BPS804 in Osteogenesis Imperfecta

Clinical trial NCT01417091 · COMPLETED

Trial details

NCT number: NCT01417091
Sponsor: Ultragenyx Pharmaceutical Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Osteogenesis Imperfecta

Start date: 2011-06-01
Primary completion: 2012-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.